Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life Bradley E. Chipps, MD, Tmirah Haselkorn, PhD, Karin Rosén, MD, PhD,

Slides:

Advertisements

Similar presentations

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey Whitney.

Advertisements

Von Ta, MD, Andrew A. White, MD

Advances in Diagnosing Peanut Allergy

Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives Iris M. Otani, MD, Sandra C. Christiansen, MD, Paula Busse, MD,

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,

Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy Thomas B. Casale, MD, Jonathan A. Bernstein,

Vitamin D Insufficiency and Asthma in a US Nationwide Study

Allergy to Surgical Implants

Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents James W. Baker, MD, Avner Reshef, MD, Dumitru Moldovan,

Chronic rhinosinusitis: Potential new use for topical sulfasalazine

Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed Leonard Bielory, MD The Journal of Allergy and Clinical Immunology:

Dennis K. Ledford, MD, Sally Wenzel, MD

Desensitization to Chemotherapeutic Agents

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy

Clinical Management of Food Allergy

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

Adult Asthma Scores—Development and Validation of Multivariable Scores to Identify Asthma in Surveys Ana Sá-Sousa, MSc, Ana Margarida Pereira, MD, Rute.

Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone- Salmeterol Combination for Asthma Management: A United States Retrospective.

Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma Allan T. Luskin,

A randomized multicenter study evaluating Xolair persistence of response after long- term therapy Dennis Ledford, MD, William Busse, MD, Benjamin Trzaskoma,

Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children Kevin R. Murphy, MD, Robert.

Melkersson-Rosenthal Syndrome

Validation of the Pregnancy Asthma Control Test

Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma Bradley E. Chipps, MD, Stanley J. Szefler,

Evaluation of Food Allergy in Patients with Atopic Dermatitis

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey Whitney.

Practice Notes from the AAAAI

Advances in Diagnosing Peanut Allergy

Erythematous Candidiasis

Nonadherence to Asthma Treatment: Getting Unstuck

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study Thomas B. Casale, MD, Allan.

William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P

Thys van der Molen, MD, PhD, Monica Fletcher, MSc, David Price, FRCGP

Consistently very poorly controlled asthma is associated with greater activity and school impairment in children with severe or difficult-to-treat asthma

Aimee L. Speck, MD, Michael Hess, MSI, Alan P. Baptist, MD, MPH

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma Hector Ortega, MD, ScD, Steven W. Yancey, MS,

Necdet B. Gunsoy, PhD, Sarah M. Cockle, PhD, Steven W

Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2 Phillip Lieberman, MD The Journal of Allergy.

Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population Stephanie J. Fox, MD, Miguel A. Park,

Development and Validation of Personalized Prediction to Estimate Future Risk of Severe Exacerbations and Uncontrolled Asthma in Patients with Asthma,

Change in Asthma Control Over Time: Predictors and Outcomes

Phillip Lieberman, MD, Michael Tankersley, MD

High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects William Busse, MD, Sheldon Spector, MD, Karin Rosén,

Effects of Mometasone, Fluticasone, and Montelukast on Bone Mineral Density in Adults with Asthma Jorge Maspero, MD, Vibeke Backer, DMSci, MD, Ruji Yao,

Thomas B. Casale, MD, Tmirah Haselkorn, PhD, Christina E

News & Notes Journal of Allergy and Clinical Immunology

The Management of Eosinophilic Esophagitis

Phillip Lieberman, MD, David Golden, MD

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study Bradley E.

Russell S. Traister, MD, PhD, Merritt L

Melkersson-Rosenthal Syndrome

Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase Phillip Lieberman, MD, Lawrence B. Schwartz, MD,

Justin R. Chen, MD, Brett L. Buchmiller, MD, David A. Khan, MD

Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M

Mapping the Asthma Care Process: Implications for Research and Practice Alexandra Lelia Dima, PhD, Marijn de Bruin, PhD, Eric Van Ganse, MD, PhD, FRCP

Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology Bradley E. Chipps, MD, Christina E. Ciaccio,

Sharon Seth, MD, David A. Khan, MD

Cephalosporin Side Chain Cross-reactivity

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma Hector Ortega, MD, ScD, Steven W. Yancey, MS,

Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency Phil Lieberman, MD, John Routes, MD The Journal.

Sophie F. Demarche, MPharm, Florence N. Schleich, MD, PhD, Virginie A

Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies Phillip Lieberman, MD, Rima Rachid, MD

News & Notes Journal of Allergy and Clinical Immunology

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe.

Reply The Journal of Allergy and Clinical Immunology: In Practice

Von Ta, MD, Andrew A. White, MD

Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012 Peter A. Lio, MD, Margaret.

Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma Stanley J. Szefler, MD, Lars-Goran Carlsson,

Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD

News & Notes Journal of Allergy and Clinical Immunology

Presentation transcript:

Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life Bradley E. Chipps, MD, Tmirah Haselkorn, PhD, Karin Rosén, MD, PhD, David R. Mink, MS, Benjamin L. Trzaskoma, MS, Allan T. Luskin, MD The Journal of Allergy and Clinical Immunology: In Practice Volume 6, Issue 1, Pages 169-176.e2 (January 2018) DOI: 10.1016/j.jaip.2017.05.027 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Patient disposition. *Number excludes 3 children who were aged 5 years at baseline. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Relationship of PAQLQ score at month 12 and (A) severity and (B) number of asthma exacerbations within the first year of follow-up. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Relationship of PAQLQ score at month 12 and number of triggers at baseline. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Relationship of the number of asthma triggers at baseline with (A) severity and (B) number of asthma exacerbations. P = .053 for overall difference in the number of asthma triggers by severity of exacerbation category. P < .001 for overall difference in the number of asthma triggers by number of exacerbation category. The Journal of Allergy and Clinical Immunology: In Practice 2018 6, 169-176.e2DOI: (10.1016/j.jaip.2017.05.027) Copyright © 2017 The Authors Terms and Conditions